Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Recidivism: later-stage trial registry
1 of 6 indexed Recidivism trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Recidivism: 6 US clinical trials tracked, 1 recruiting.
Recidivism is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ginger Yang, running 2 of these trials.
Enrollment posture brief
Registry condition recidivism
OPEN 1 | RECR 17% | LATE 2 | EARLY 0 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)
Recidivism lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Recidivism on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Recidivism is recruiting below its size-band peers.
1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Recidivism research.
Ginger Yang accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Recidivism enrolment sits around 400 participants.
Median target enrolment is 400 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.
-
Recidivism research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Teen Driving Translation Study (NIH)
Ginger Yang
NCT05696353
Supportive Release Center Study
University of Chicago
NCT03616990
Re-entry Continuum for Brain Injury
Rehabilitation Hospital of Indiana
NCT04386681
An Outcome Evaluation of the Project CHANGE-MS Violence Intervention Program
Medstar Health Research Institute
NCT04567381
Intervention to Improve Driving Practices Among High-Risk Teen Drivers
Ginger Yang
NCT04317664
Three-Principles Approach for Incarcerated Adults
Pacific University
NCT04747704
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Recidivism records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Recidivism trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Recidivism page
6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Recidivism trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ginger Yang sponsors the most Recidivism trials on record, review their full trial history before evaluating a specific study. See Ginger Yang's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Recidivism condition card totals 6 registered trials; most-linked intervention Enhanced Services; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.